Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank57
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-104.57M
↓ 17% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-89.46M
Historical baseline
PeriodValueYoY Change
TTM$-104.57M+25.2%
2024$-139.71M-5.6%
2023$-132.28M-7.1%
2022$-123.54M-8.6%
2021$-113.73M-93.5%
2020$-58.76M-109.1%
2019$-28.11M-87.7%
2018$-14.97M-